Log in to save to my catalogue

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5a734dbbd52a444ea8aff078384df83d

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

About this item

Full title

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2018-09, Vol.9 (1), p.3600-17, Article 3600

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Expression of androgen receptor (AR) in prostate cancer (PCa) is heterogeneous but the functional significance of AR heterogeneity remains unclear. Screening ~200 castration-resistant PCa (CRPC) cores and whole-mount sections (from 89 patients) reveals 3 AR expression patterns: nuclear (nuc-AR), mixed nuclear/cytoplasmic (nuc/cyto-AR), and low/no e...

Alternative Titles

Full title

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5a734dbbd52a444ea8aff078384df83d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5a734dbbd52a444ea8aff078384df83d

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-06067-7

How to access this item